Zugi AI

About
What does Zugi AI do?
Zugi AI provides Investment Intelligence™ Solutions powered by Artificial Investment Intelligence™ (Aii™) for modern capital allocators. Its vertically integrated AI system, including ZugiGPT, is built for venture capital, private equity, and strategic diligence workflows, offering tools like a Sourcing/Screening Assistant and Deep-Dive Analyst Co-pilot. Zugi AI serves a range of investors from solo GPs and angels to institutional firms, enabling them to think, decide, and deploy capital with cl…
What is Zugi AI's revenue?
StartupHub estimates Zugi AI's annual revenue at $660K (range $383K to $1.1M, 64% confidence), based on comparable companies in the sector.
Where is Zugi AI headquartered?
Zugi AI is headquartered in Tel Aviv, Israel.
When was Zugi AI founded?
Zugi AI was founded in 2023.
What industry does Zugi AI operate in?
Zugi AI operates in Venture Capital, Fundraising Platform, Cap Table Management, Investor Relations, AI Tools & Apps, Fintech.
How many employees does Zugi AI have?
Zugi AI has approximately 3 people on record.
AI-powered CRM and fundraising platform for startups and venture capital.
MIRAMONTE is a Spain-based international holding company focused on strategic investments and long-term value creation.
AI-powered platform connecting startups with investors and advisors.
Global software investor focused on high-growth technology and software companies.
AI venture-evaluation platform that clears the evaluation gate and delivers on a rev-share basis.
Antennafunds is an AI-powered platform for venture capital deal sourcing and investment analysis.
AI-powered platform for deal sourcing and intelligence for investors.
A venture builder and holding company creating and scaling high-growth startups in global markets.
An entrant is a company tagged Venture Capital whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
